Congo Ebola Outbreak: 600 Dead, New Cases Spread to Two Provinces

The Democratic Republic of Congo's latest Ebola outbreak, driven by the rare Bundibugyo virus, has escalated into the fastest-growing Ebola epidemic on the African continent, with the death toll surpassing 600 and confirmed cases climbing to 1,759 as of early July 2026. The government confirmed on Thursday that suspected cases have now been recorded in Tshopo and Haut-Uele provinces, marking the first time the disease has spread beyond the epicenter in Ituri region. One case in Kisangani, Tshopo's provincial capital, has no apparent epidemiological link to known outbreaks, raising the specter of undetected transmission chains that could accelerate the crisis. Authorities declared the outbreak on May 15 after weeks of silent transmission, according to the World Health Organization. The pathogen, Bundibugyo ebolavirus, first identified in Uganda in 2007, has no approved vaccine or treatment, leaving responders reliant on basic containment and supportive care. The fatality rate for Bundibugyo historically ranges from 25% to 40%, and with 600 deaths among 1,759 confirmed cases, the current case fatality ratio stands at roughly 34%, aligning with past outbreaks. The Africa Centre for Disease Control and Prevention warned on Thursday that this is the fastest-growing Ebola outbreak on the continent, underscoring the urgency. Efforts to contain the virus face multiple impediments. A critical funding gap, attacks on health centers, and an ongoing conflict in eastern Congo have hampered response operations. Compounding these challenges, health workers in Ituri's capital Bunia staged protests on Thursday outside three treatment centers—Centre Medical Evangelique, Elikya, and Salama—demanding unpaid wages. Police dispersed one of the protests, but it remains unclear whether the demonstrations disrupted clinical care. Health Minister Samuel Roger Kamba acknowledged "problems with the human resources pillar of the response," specifically with updating payment lists, highlighting systemic weaknesses in workforce management during health emergencies. On the research front, clinical trials for treatments were launched last week at the Evangelical Medical Center in Bunia, offering a glimmer of hope. However, the absence of any approved countermeasures for Bundibugyo places immense pressure on these trials to deliver results quickly while navigating ethical and logistical hurdles in a conflict zone. The spread to previously unaffected provinces signals that containment has not been achieved, and the unlinked case in Kisangani suggests hidden transmission networks that could seed new clusters. The international community must grapple not only with the biomedical challenge of a neglected virus but also with the structural failures in health systems, funding, and security. Looking ahead, the response will hinge on rapidly scaling up surveillance, ensuring health workers are paid to maintain their morale, and accelerating clinical research. The Bundibugyo outbreak serves as a stark reminder that global health security relies on addressing both the pathogen and the fragile systems it exploits. Without swift and well-resourced action, the outbreak could spiral further, threatening neighboring regions and overwhelming a health system already battered by conflict and previous Ebola crises.